V

Valneva Tech Stack

Specialty vaccine manufacturer for Lyme disease, chikungunya, and travel medicine

Biotechnology Research Saint-Herblain, Pays de la Loire 501–1,000 employees Founded 2013 Public Company

Valneva is a public biotech company developing and manufacturing vaccines for infectious diseases with limited treatment options, including marketed chikungunya and Lyme disease candidates. The tech stack is entirely Microsoft-centric (Dynamics 365, Azure, Microsoft 365), with active projects clustered around ERP migration, finance digitalization, and quality-control process validation—a hiring pattern (9 senior roles across finance, manufacturing, and operations) that reflects organizational restructuring rather than R&D scaling, suggesting operational maturation and regulatory compliance infrastructure upgrades drive current priorities over pipeline expansion.

Tech Stack 23 technologies

Core StackDynamics 365 Azure AD Windows Server Active Directory Workiva Excel Word PowerPoint Dynamics 365 Finance and Operations Azure Microsoft 365 Exchange Online SharePoint Teams OneDrive Azure AD Connect Azure Portal PowerShell DLP Purview Dynamics 365 Supply Chain Management Microsoft Dynamics 365 Microsoft Office

What Valneva Is Building

◆Challenges

Reducing significant deviations
Improving qc processes
Optimizing consolidation systems
Digitalizing finance processes
Process improvements across finance systems
Migration activities
Ensuring compliance with ifrs and fgaap
Managing tax reporting requirements
Internal audit coordination
Erp upgrade

▲Active Projects

Quality control validation master plan (vmp)
Change control initiatives
Implementation of consolidation systems
Digitalization of finance processes
Rollout of ifrs 18
Local change cases
Strategic finance projects
Erp implementation and migration
Erp upgrade
Audit file preparation

Hiring Activity

Accelerating20 roles · 10 in 30d

Department

Finance

5

Manufacturing

3

Research

3

HR

2

Legal

2

Operations

1

Ops

1

Quality

1

Seniority

Senior

9

Mid

8

Junior

1

Manager

1

Company intelligence

Find more companies like Valneva by tech stack, pain points and active projects

Get started free

About Valneva

Valneva manufactures prophylactic vaccines targeting unmet infectious disease needs, operating across six countries with approximately 700 employees. The company markets three proprietary travel vaccines and is developing candidates for Lyme disease (in partnership with Pfizer), Zika, and other public health threats. Manufacturing and commercialization infrastructure spans Austria, Sweden, the UK, France, Canada, and the US. Current operational focus centers on ERP implementation, finance process modernization, and quality control standardization—typical of a mid-stage biotech maturing its operations alongside clinical development.

HeadquartersSaint-Herblain, Pays de la Loire

Company Size501–1,000 employees

Founded2013

Hiring MarketsSweden, Austria, Canada, France, United Kingdom

Frequently Asked Questions

What is Valneva's technology stack?

Valneva uses Microsoft Dynamics 365 (Finance, Operations, Supply Chain), Azure cloud services, Microsoft 365 (Teams, SharePoint, Exchange), Active Directory, and Office tools. No custom development platforms are evident in the public tech footprint.

Where is Valneva headquartered?

Valneva is headquartered in Saint-Herblain, Pays de la Loire, France. Operations span Austria, Sweden, the United Kingdom, Canada, and the United States.